Synergistic retention strategy of RGD active targeting and radiofrequency-enhanced permeability for intensified RF & chemotherapy synergistic tumor treatment

详细信息    查看全文

• 作者：Kun Zhang^a ; ^b ; ¹ ; Pei Li^a ; ^b ; ¹ ; Yaping He^a ; ^b ; Xiaowan Bo^a ; Xiaolong Li^a ; Dandan Li^a ; Hangrong Chen^c ; ^{hrchen@mail.sic.ac.cn" class="auth_mail" title="E-mail the corresponding author} ; Huixiong Xu^a ; ^b ; ^{xuhuixiong@l26.com" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Synergistic retention ; RGD active targeting ; Radiofrequency (RF)-enhanced permeability ; RF ablation ; Chemotherapy ; RF-responsive drug delivery
• 刊名：Biomaterials
• 出版年：2016
• 出版时间：August 2016
• 年：2016
• 卷：99
• 期：Complete
• 页码：34-46
• 全文大小：3739 K

文摘

Despite gaining increasing attention, chelation of multiple active targeting ligands greatly increase the formation probability of protein corona, disabling active targeting. To overcome it, a synergistic retention strategy of RGD-mediated active targeting and radiofrequency (RF) electromagnetic field-enhanced permeability has been proposed here. It is validated that such a special synergistic retention strategy can promote more poly lactic-co-glycolic acid (PLGA)-based capsules encapsulating camptothecin (CPT) and solid DL-menthol (DLM) to enter and retain in tumor in vitro and in vivo upon exposure to RF irradiation, receiving an above 8 fold enhancement in HeLa retention. Moreover, the PLGA-based capsules can respond RF field to trigger the entrapped DLM to generate solid-liquid-gas (SLG) tri-phase transformation for enhancing RF ablation and CPT release. Therefore, depending on the enhanced RF ablation and released CPT and the validated synergistic retention effect, the inhibitory outcome for tumor growth has gained an over 10-fold improvement, realizing RF ablation & chemotherapy synergistic treatment against HeLa solid tumor, which indicates a significant promise in clinical RF ablation.